Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982

Online
ISSN
1437-4331
See all formats and pricing
In This Section
Volume 44, Issue 4 (Apr 2006)

Issues

The dilemma of invasive and non-invasive investigations for adult and paediatric non-alcoholic fatty liver disease: has the time come for a new biochemical marker?

Mohamed Hassan Ahmed
  • Chemical Pathology Department, Level D, South Academic Block, Southampton General Hospital, Southampton, UK
Published Online: 2011-09-21 | DOI: https://doi.org/10.1515/CCLM.2006.081

References

  • 1.

    Ahmed MH, Byrne CD. Non-alcoholic steatoheptatitis. In: Byrne CD, Wild S, editors. Metabolic syndrome. Chichester, UK: Wiley & Sons 2005:279–303.

  • 2.

    Ahmed MH. Invasive and non-invasive investigations for non-alcoholic steatohepatitis: the benefit of histology. Scand J Gastroenterol 2005; 40:1260. [Crossref]

  • 3.

    Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al., LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128:1898–906. [Crossref]

  • 4.

    Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005; 42:641–9. [Crossref]

  • 5.

    Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129:113–21. [Crossref]

  • 6.

    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047–53.

  • 7.

    Mardini H, Record C. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Ann Clin Biochem 2005; 42:441–7. [Crossref]

About the article

Corresponding author: M.H. Ahmed, MD, PhD, Chemical Pathology Department, Mail point 6, Level D South Academic Block, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK Phone: +44-2380-793465, Fax: +44-2380-796339,


Published Online: 2011-09-21

Published in Print: 2006-04-01



Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2006.081. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Mohamed H Ahmed, Rasheed A Saad, and Meissa M Osman
Expert Opinion on Drug Safety, 2006, Volume 5, Number 4, Page 487

Comments (0)

Please log in or register to comment.
Log in